New treatment discovered for rare eye disease may prevent blindness

(Cedars-Sinai Medical Center) Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in their symptoms, appearance and quality of life, according to a study recently published in the New England Journal of Medicine.